Physician profile
Stephen D Major
NPI 1902095151
$1,526.27
in general payments reported to CMS, 2019-2025
7 companies · $29.41 in 2025
The $29.41 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $14.87 · 2021: $68.71 · 2022: $25.81 · 2023: $1,241 · 2025: $29.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,238 · Food and Beverage: $33.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,237.50 |
| Food and Beverage | $33.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $1,241.14 | 2023 | |
| Mylan Specialty L.P. | $109.22 | 2019 | |
| Glaxosmithkline, LLC. | $71.12 | 2019-2022 | |
| Pulmonx Corporation | $65.60 | 2021-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Novartis Pharmaceuticals Corporation | $13.70 | 2019 | |
| Amgen INC. | $13.41 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Major listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.